Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer
Open Access
- 29 April 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 10 (1), 172-10
- https://doi.org/10.1186/1471-2407-10-172
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survivalEuropean Respiratory Journal, 2009
- Pathways connecting inflammation and cancerCurrent Opinion in Genetics & Development, 2008
- Macrophage and Mast-Cell Invasion of Tumor Cell Islets Confers a Marked Survival Advantage in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- The chemokine system in diverse forms of macrophage activation and polarizationTrends in Immunology, 2004
- Interleukin-8/CXCL8 is a growth factor for human lung cancer cellsBritish Journal of Cancer, 2004
- Cancer and the chemokine networkNature Reviews Cancer, 2004
- The Stromal Derived Factor–1/CXCL12–CXC Chemokine Receptor 4 Biological Axis in Non–Small Cell Lung Cancer MetastasesAmerican Journal of Respiratory and Critical Care Medicine, 2003
- RANTES expression is a predictor of survival in stage I lung adenocarcinoma.2002
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.The Journal of Experimental Medicine, 1994